SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.88+0.2%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Olu Emuleomo who started this subject6/25/2004 10:13:13 PM
From: Robert K.  Read Replies (1) of 17367
 
Found this on the net as a comment on Raptiva.
Means absolutely NOTHING, but I find it interesting thatthe poster has a very good knowledge base and knows his/her topic well.
That said they may not be blowing smoke.
Here is the comment
"They are also looking at Raptiva for MS. All of these autoimmune diseases seem to respond to certain compounds."
As usual, standard K disclaimers always apply.
No facts
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News